The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study
Open accessAbstract
OBJECTIVE: To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. DESIGN: Population based, prospective cohort study with follow-up over three years. SETTING: New South Wales, Australia. PARTICIPANTS: Men with localised prostate cancer were eligible if aged less than 70 years, diagnosed between October 2000 and October 2002, and notified to the New South Wales central cancer registry. Controls were randomly selected from the New South Wales electoral roll and matched to cases by age and postcode. MAIN OUTCOME MEASURES: General health specific and disease specific function up to three years after diagnosis, according to the 12 item short form health survey and the University of California, Los Angeles prostate cancer index. RESULTS: 1642 (64%) cases and 495 (63%) eligible and contacted controls took part in the study. After adjustment for confounders, all active treatment groups had low odds of having better sexual function than controls, in particular men on androgen deprivation therapy (adjusted odds ratio (OR) 0.02, 95% CI 0.01 to 0.07). Men treated surgically reported the worst urinary function (adjusted OR 0.17, 95% CI 0.13 to 0.22). Bowel function was poorest in cases who had external beam radiotherapy (adjusted OR 0.44, 95% CI 0.30 to 0.64). General physical and mental health scores were similar across treatment groups, but poorest in men who had androgen deprivation therapy. CONCLUSIONS: The various treatments for localised prostate cancer each have persistent effects on quality of life. Sexual dysfunction three years after diagnosis was common in all treatment groups, whereas poor urinary function was less common. Bowel function was most compromised in those who had external beam radiotherapy. Men with prostate cancer and the clinicians who treat them should be aware of the effects of treatment on quality of life, and weigh them up against the patient's age and the risk of progression of prostate cancer if untreated to make informed decisions about treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
(1994) · Medical Entomology and Zoology · Cited by 4,156
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & The Measurement Committee of the American Urological Association (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36966-5 · Cited by 3,436
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O'leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & Measurement Committee of the American Urological Association (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.071 · Cited by 1,940
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
PENSON, D. F., McLERRAN, D., FENG, Z., LI, L., ALBERTSEN, P. C., GILLILAND, F. D., HAMILTON, A., HOFFMAN, R. M., STEPHENSON, R. A., POTOSKY, A. L., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000154637.38262.3a · Cited by 559
Donovan, J., Little, P., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., Frankel, S., Neal, D., & Hamdy, F. (2002) · BMJ · doi:10.1136/bmj.325.7367.766 · Cited by 533
Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
Walsh, P. C., Marschke, P., Ricker, D., & Burnett, A. L. (2000) · Urology · doi:10.1016/s0090-4295(99)00397-0 · Cited by 513
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
RABBANI, F., STAPLETON, A. M. F., KATTAN, M. W., WHEELER, T. M., & SCARDINO, P. T. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)66921-2 · Cited by 487
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Coleman, M. P., Gatta, G., Verdecchia, A., Estève, J., Sant, M., Storm, H., Allemani, C., Ciccolallo, L., Santaquilani, M., & Berrino, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg756 · Cited by 483
The Surgical Learning Curve for Prostate Cancer Control After Radical Prostatectomy
Vickers, A. J., Bianco, F. J., Serio, A. M., Eastham, J. A., Schrag, D., Klein, E. A., Reuther, A. M., Kattan, M. W., Pontes, J. E., & Scardino, P. T. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm060 · Cited by 402
LITWIN, M. S., LUBECK, D. P., HENNING, J. M., & CARROLL, P. R. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63222-1 · Cited by 401
Prostate cancer and health‐related quality of life: a review of the literature
Eton, D. T., & Lepore, S. J. (2002) · Psycho-Oncology · doi:10.1002/pon.572 · Cited by 346
Adaptation to changing health: Response shift in quality-of-life research.
(2000) · American Psychological Association eBooks · doi:10.1037/10382-000 · Cited by 301
Active surveillance for early‐stage prostate cancer: Review of the current literature
Dall'Era, M. A., Cooperberg, M. R., Chan, J. M., Davies, B. J., Albertsen, P. C., Klotz, L. H., Warlick, C. A., Holmberg, L., Bailey, D. E., Wallace, M. E., et al. (2008) · Cancer · doi:10.1002/cncr.23373 · Cited by 273
Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study
Potosky, A. L., Harlan, L. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. S., Albertsen, P. C., Eley, J. W., Liff, J. M., Deapen, D., Stephenson, R. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.20.1719 · Cited by 215
Chen, R. C., Clark, J. A., & Talcott, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6486 · Cited by 199
Korfage, I. J., Essink‐Bot, M., Borsboom, G. J. J. M., Madalinska, J. B., Kirkels, W. J., Habbema, J. D. F., Schröder, F. H., & de Koning, H. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21043 · Cited by 195
Penson, D. F., Feng, Z., Kuniyuki, A., McClerran, D., Albertsen, P. C., Deapen, D., Gilliland, F., Hoffman, R., Stephenson, R. A., Potosky, A. L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.139 · Cited by 190
Litwin, M. S., & McGuigan, K. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2882 · Cited by 158
Smith, D. P., Supramaniam, R., King, M. T., Ward, J., Berry, M. P., & Armstrong, B. K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8046 · Cited by 140
Self-citationLong‐term quality of life among Dutch prostate cancer survivors: Results of a population‐based study
Mols, F., van de Poll-Franse, L. V., Vingerhoets, A. J. J. M., Hendrikx, A. J. M., Aaronson, N. K., Houterman, S., Coebergh, J. W. W., & Essink‐Bot, M. (2006) · Cancer · doi:10.1002/cncr.22231 · Cited by 84
Johnson, T. K., Gilliland, F. D., Hoffman, R. M., Deapen, D., Penson, D. F., Stanford, J. L., Albertsen, P. C., & Hamilton, A. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.127 · Cited by 70
Arredondo, S. A., Downs, T. M., Lubeck, D. P., Pasta, D. J., Silva, S. J., Wallace, K. L., & Carroll, P. R. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000140758.04424.77 · Cited by 66
Hoffman, R. M., Gilliland, F. D., Penson, D. F., Stone, S. N., Hunt, W. C., & Potosky, A. L. (2004) · Cancer · doi:10.1002/cncr.20608 · Cited by 64
Validation Study of Retrospective Recall of Disease-Targeted Function
Legler, J., Potosky, A. L., Gilliland, F. D., Eley, J. W., & Stanford, J. L. (2000) · Medical Care · doi:10.1097/00005650-200008000-00008 · Cited by 60
Comparative effectiveness of therapies for clinically localized prostate cancer
(2009) · Clinical Governance An International Journal · doi:10.1108/cgij.2009.24814bae.009 · Cited by 52
Trends in Treatment Costs for Localized Prostate Cancer
Zeliadt, S. B., Etzioni, R., Ramsey, S. D., Penson, D. F., & Potosky, A. L. (2007) · Medical Care · doi:10.1097/01.mlr.0000241044.09778.3f · Cited by 44
Quality of Life After Therapy for Localized Prostate Cancer
Penson, D. F. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e3181570121 · Cited by 43
Arredondo, S. A., Downs, T. M., Lubeck, D. P., Pasta, D. J., Silva, S. J., Wallace, K. L., & Carroll, P. R. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.03.132 · Cited by 18
Cited by
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606221 · Cited by 1,338
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.046 · Cited by 1,079
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Fenton, J. J., Weyrich, M. S., Durbin, S., Liu, Y., Bang, H., & Melnikow, J. (2018) · JAMA · doi:10.1001/jama.2018.3712 · Cited by 555
Quality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Metadata
- Authors
- Smith, D. P., King, M. T., Egger, S., Berry, M. P., Stricker, P. D., Cozzi, P., Ward, J., O'Connell, D. L., & Armstrong, B. K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-11-27
- Volume
- 339
- Issue
- nov27 2
- Pages
- b4817-b4817
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2040008722
- Cited by
- 286
- References
- 35
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.